The state animal welfare officers with expertise in the field of animal testing and alternatives have established a working group to develop key points for reducing animal testing and switching to animal-free research technologies.

Professor Dr. Peter Loskill and Dr. Silke Riegger from the University of Tübingen have been awarded this year's Ursula M. Händel Animal Welfare Prize by the German Research Foundation (DFG). According to the jury, with their development, application and dissemination of organ-on-chip systems, they are contributing significantly to replacing animal models with suitable alternatives.

In an in vitro study, the scientists Lydia Kürzinger and Benedikt Pötzl from the Department of Endocrinology and Diabetology at University Hospital Würzburg have investigated the effects of bisphenols on adrenal hormone synthesis. They made some interesting discoveries.

Each year, four joung researchers are selected to receive up to US$30,000 in prize money for their accomplishments.

Together with researchers from the Hans Knöll Institute and Jena University Hospital, the Jena-based biotech company Dynamic42 has developed a gut-on-chip candidiasis model that can be used to quantify the course of infection.

In cell cultures obtained from volunteers, a team of scientists has discovered that tobacco consumption triggers profound epigenetic changes that are assumed to be associated with a long-term cancer risk. This apparently also applies to e-cigarettes, which are touted as an alternative.

The Experimental Endoscopy, Development and Training (EEET) working group at Tübingen University Hospital, headed by Dr. Dörte Wichmann, is developing innovative models that accurately reflect human anatomy without using animal materials.

Rare diseases: Animal-free research

Thursday, 29 February 2024 11:34

On the occasion of today's Rare Disease Day, the Federal Association of People for Animal Rights emphasizes the importance of research into these diseases using new, non-animal methods (NAMs).

Scientists from the Institute of Quantitative Biomedicine at the University of Zurich have developed an innovative cell culture model with nerve cells to investigate a dysregulated protein in patients with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

Using patient blood, a team of researchers from Dublin has succeeded in identifying a cause of the consequences of coronavirus infection known as long COVID and brain fog.

Page 1 of 87